Exploring the treatment of SARS-CoV-2 with modified vesicular stomatitis virus
From MaRDI portal
Publication:6671174
DOI10.1016/J.JTBI.2024.111959MaRDI QIDQ6671174
Hana M. Dobrovolny, Nishnath Polavarapu, Madison Doty
Publication date: 24 January 2025
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Medical applications (general) (92C50) Qualitative investigation and simulation of ordinary differential equation models (34C60)
Cites Work
- Assessing uncertainty in A2 respiratory syncytial virus viral dynamics
- On the extinction probability in models of within-host infection: the role of latency and immunity
- Intermittent treatment of severe influenza
- Superinfection and cell regeneration can lead to chronic viral coinfections
- Modeling amantadine treatment of influenza A virus in vitro
- Neuraminidase inhibitors for treatment of human and avian strain influenza: a comparative modeling study
- The quantitative theory of within-host viral evolution
- The impact of cell regeneration on the dynamics of viral coinfection
This page was built for publication: Exploring the treatment of SARS-CoV-2 with modified vesicular stomatitis virus
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6671174)